These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 14646611

  • 1. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH, Byun HJ.
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [Abstract] [Full Text] [Related]

  • 2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN, Matroos GE, Hoek HW, Kahn RS.
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.
    Desai N, Patel PB, Shah S, Patel TK, Shah SN, Vatsala E.
    Int J Psychiatry Clin Pract; 2018 Jun; 22(2):101-108. PubMed ID: 28952832
    [Abstract] [Full Text] [Related]

  • 5. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
    Hansen L, Jones RM, Kingdon D.
    J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982
    [Abstract] [Full Text] [Related]

  • 6. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Carbon M, Kapoor S, Sheridan E, Al-Jadiri A, Azzo S, Sarkaria T, Kane JM, Saito E, Correll CU.
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J.
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [Abstract] [Full Text] [Related]

  • 8. Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review.
    Halliday J, Farrington S, Macdonald S, MacEwan T, Sharkey V, McCreadie R.
    Br J Psychiatry; 2002 Nov; 181():422-7. PubMed ID: 12411269
    [Abstract] [Full Text] [Related]

  • 9. Motor and mental side effects of clozapine.
    Gerlach J, Peacock L.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [Abstract] [Full Text] [Related]

  • 10. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS.
    Schizophr Res; 1997 Aug 29; 26(2-3):235-42. PubMed ID: 9323356
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.
    Gebhardt S, Härtling F, Hanke M, Mittendorf M, Theisen FM, Wolf-Ostermann K, Grant P, Martin M, Fleischhaker C, Schulz E, Remschmidt H.
    Eur Child Adolesc Psychiatry; 2006 Oct 29; 15(7):371-82. PubMed ID: 16648965
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 13. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.
    Gebhardt S, Härtling F, Hanke M, Theisen FM, von Georgi R, Grant P, Mittendorf M, Martin M, Fleischhaker C, Schulz E, Remschmidt H.
    Eur Child Adolesc Psychiatry; 2008 Feb 28; 17(1):44-53. PubMed ID: 17876506
    [Abstract] [Full Text] [Related]

  • 14. [Prevalence of extrapyramidal effects by neuroleptics in admitted people with schizophrenia].
    Moreno-Calvete MC.
    Enferm Clin; 2013 Feb 28; 23(3):114-7. PubMed ID: 23755945
    [Abstract] [Full Text] [Related]

  • 15. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
    Jung HY, Kim JH, Ahn YM, Kim SC, Hwang SS, Kim YS.
    Hum Psychopharmacol; 2005 Jan 28; 20(1):41-5. PubMed ID: 15565639
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and characteristics of patients with pseudoakathisia.
    Havaki-Kontaxaki BJ, Kontaxakis VP, Christodoulou GN.
    Eur Neuropsychopharmacol; 2000 Sep 28; 10(5):333-6. PubMed ID: 10974603
    [Abstract] [Full Text] [Related]

  • 17. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR.
    Psychiatr Dev; 1987 Sep 28; 5(4):301-19. PubMed ID: 2895467
    [Abstract] [Full Text] [Related]

  • 18. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P, Hume F, Toohey P, Doutney C.
    Acta Psychiatr Scand; 1996 Jun 28; 93(6):451-9. PubMed ID: 8831862
    [Abstract] [Full Text] [Related]

  • 19. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.
    Sundram S, Lambert T, Piskulic D.
    Acta Psychiatr Scand; 2008 Jun 28; 117(6):474-8. PubMed ID: 18479320
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL, Wagner RL.
    J Clin Psychiatry; 1988 Nov 28; 49(11):435-8. PubMed ID: 2903141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.